Deferasirox Tablets For Oral Suspension and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Deferasirox Tablets For Oral Suspension and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: deferasirox
Brand name: Exjade, Jadenu, Jadenu Sprinkle
Synonyms: Deferasirox
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Deferasirox Tablets For Oral Suspension-Insulin degludec
- Deferasirox Tablets For Oral Suspension-Insulin Degludec (U-100) Prefilled Pens
- Deferasirox Tablets For Oral Suspension-Insulin Degludec (U-100) Vials
- Deferasirox Tablets For Oral Suspension-Insulin Degludec (U-200) Prefilled Pens
- Deferasirox Tablets For Oral Suspension-Insulin degludec and liraglutide
- Deferasirox Tablets For Oral Suspension-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Deferiprone
- Insulin aspart, recombinant Subcutaneous-Deferiprone Oral Solution
- Insulin aspart, recombinant Subcutaneous-Deferiprone Tablets
- Insulin aspart, recombinant Subcutaneous-Deferoxamine
- Insulin aspart, recombinant Subcutaneous-Deferoxamine Injection
- Insulin aspart, recombinant Subcutaneous-Deferoxamine Mesylate